NLM Logo

EMA-CO protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
EMA-CO protocol
Unique ID
C048014
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C048014
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Dactinomycin
Etoposide
Methotrexate
Vincristine
Frequency
124
Note
chemotherapy protocol containing etoposide, methotrexate & dactinomycin (EMA) , vincristine & cyclophosphamide (CO); EMA & CO are given on alternate weeks; for therapy of gestational trophoblastic tumors
Source
Br J Obstet Gynaecol 1986;93(1):63
Date of Entry
1986/03/20
Revision Date
2000/11/30
EMA-CO protocol Preferred
page delivered in 0.003s